GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Total Assets

Tatva Chintan Pharma Chem (BOM:543321) Total Assets : ₹8,187 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Total Assets?

Tatva Chintan Pharma Chem's Total Assets for the quarter that ended in Mar. 2024 was ₹8,187 Mil.

Warning Sign:

If a company builds assets at 38.8% a year, faster than its revenue growth rate of 13% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Tatva Chintan Pharma Chem's average Total Assets Growth Rate was 5.80% per year. During the past 3 years, the average Total Assets Growth Rate was 35.90% per year. During the past 5 years, the average Total Assets Growth Rate was 38.80% per year.

During the past 6 years, Tatva Chintan Pharma Chem's highest 3-Year average Total Assets Growth Rate was 51.10%. The lowest was 35.90%. And the median was 45.00%.

Total Assets is connected with ROA %. Tatva Chintan Pharma Chem's annualized ROA % for the quarter that ended in Mar. 2024 was 4.70%. Total Assets is also linked to Revenue through Asset Turnover. Tatva Chintan Pharma Chem's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.


Tatva Chintan Pharma Chem Total Assets Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Total Assets Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial 2,489.38 3,148.03 6,580.55 7,563.00 8,187.18

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,563.00 - 8,402.41 - 8,187.18

Tatva Chintan Pharma Chem Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tatva Chintan Pharma Chem's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=7370.82+816.36
=8,187

Tatva Chintan Pharma Chem's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=7370.82+816.36
=8,187

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem  (BOM:543321) Total Assets Explanation

Total Assets is connected with ROA %.

Tatva Chintan Pharma Chem's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=384.56/( (0+8187.18)/ 1 )
=384.56/8187.18
=4.70 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tatva Chintan Pharma Chem's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=982.66/( (0+8187.18)/ 1 )
=982.66/8187.18
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tatva Chintan Pharma Chem Total Assets Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines